Corrigendum to 'Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation' [Biomater. Adv. 145 (2023) 213266]
Biomater Adv. 2023 May:148:213350.
doi: 10.1016/j.bioadv.2023.213350.
Epub 2023 Feb 28.
1 Nanomedicine Research Group, Department of Pharmacy Quaid-i-Azam University, 45320 Islamabad, Pakistan; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, 45320 Islamabad, Pakistan.
2 Nanomedicine Research Group, Department of Pharmacy Quaid-i-Azam University, 45320 Islamabad, Pakistan; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, 45320 Islamabad, Pakistan. Electronic address: fudin@qau.edu.pk.
3 Institute of Biotechnology and Microbiology, Bacha Khan University, Charsada, KPK, Pakistan.
4 Nanomedicine Research Group, Department of Pharmacy Quaid-i-Azam University, 45320 Islamabad, Pakistan; Lahore School of Clinical Pharmacy, Faculty of Pharmacy, University of Lahore, Lahore, Pakistan.
5 Nanomedicine Research Group, Department of Pharmacy Quaid-i-Azam University, 45320 Islamabad, Pakistan.
6 College of Pharmacy, Hanyang University, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan 15588, South Korea. Electronic address: hangon@hanyang.ac.kr.
7 Nanomedicine Research Group, Department of Pharmacy Quaid-i-Azam University, 45320 Islamabad, Pakistan; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, 45320 Islamabad, Pakistan; Islamia College University, Peshawar, Khyber Pakhtunkhwa, Pakistan. Electronic address: gmkhan@qau.edu.pk.